Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.19−0.31 (-1.38%)
Close on Nov 20, 2026Market cap $451.80MP/E –Yield –
Assembly Biosciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Assembly Biosciences's free cash flow for the twelve months ending Jun 30, 2026 was -$38.57M. For fiscal 2025 it was -$41.16M. The highest annual figure on record is $22.49M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$41.16M | – |
| FY2024 | Dec 31, 2024 | -$51.15M | -327.4% |
| FY2023 | Dec 31, 2023 | $22.49M | – |
| FY2022 | Dec 31, 2022 | -$84.57M | – |
| FY2021 | Dec 31, 2021 | -$96.49M | – |
| FY2020 | Dec 31, 2020 | -$63.43M | – |
| FY2019 | Dec 31, 2019 | -$85.62M | – |
| FY2018 | Dec 31, 2018 | -$65.30M | -6662.6% |
| FY2017 | Dec 31, 2017 | $995.00K | – |
| FY2016 | Dec 31, 2016 | -$35.03M | – |
| FY2015 | Dec 31, 2015 | -$18.76M | – |
| FY2014 | Dec 31, 2014 | -$15.12M | – |
| FY2013 | Dec 31, 2013 | -$17.80M | – |
| FY2012 | Dec 31, 2012 | -$21.38M | – |
| FY2011 | Dec 31, 2011 | -$25.08M | – |
| FY2010 | Dec 31, 2010 | -$5.21M | – |
| FY2009 | Dec 31, 2009 | -$3.49M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$15.49M | – |
| Q1 FY2026 | Mar 31, 2026 | -$22.12M | – |
| Q4 FY2025 | Dec 31, 2025 | $14.21M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.18M | – |
| Q2 FY2025 | Jun 30, 2025 | -$16.76M | – |
| Q1 FY2025 | Mar 31, 2025 | -$23.44M | – |
| Q4 FY2024 | Dec 31, 2024 | -$407.00K | -100.6% |
| Q3 FY2024 | Sep 30, 2024 | -$15.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$17.12M | – |
| Q1 FY2024 | Mar 31, 2024 | -$18.38M | – |
| Q4 FY2023 | Dec 31, 2023 | $73.58M | – |
| Q3 FY2023 | Sep 30, 2023 | -$13.98M | – |
| Q2 FY2023 | Jun 30, 2023 | -$13.68M | – |
| Q1 FY2023 | Mar 31, 2023 | -$23.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$19.25M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.92M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.89M | – |
| Q1 FY2022 | Mar 31, 2022 | -$27.50M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.38M | – |
| Q3 FY2021 | Sep 30, 2021 | -$18.88M | -277.4% |
| Q2 FY2021 | Jun 30, 2021 | -$21.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$36.42M | – |
| Q4 FY2020 | Dec 31, 2020 | -$25.27M | – |
| Q3 FY2020 | Sep 30, 2020 | $10.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$23.52M | – |
| Q1 FY2020 | Mar 31, 2020 | -$25.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$20.54M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.60M | – |
| Q2 FY2019 | Jun 30, 2019 | -$21.06M | – |
| Q1 FY2019 | Mar 31, 2019 | -$25.43M | – |
| Q4 FY2018 | Dec 31, 2018 | -$16.94M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.72M | – |
| Q2 FY2018 | Jun 30, 2018 | -$16.10M | – |
| Q1 FY2018 | Mar 31, 2018 | -$15.54M | -144.5% |
| Q4 FY2017 | Dec 31, 2017 | -$10.13M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.46M | – |
| Q2 FY2017 | Jun 30, 2017 | -$12.36M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.94M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.15M | – |
| Q3 FY2016 | Sep 30, 2016 | -$7.90M | – |
See a number that looks wrong?